Europe’s chemicals collapse is a wake-up call: overregulation, high energy costs, and cheap Chinese imports are hollowing out vital capacity, and the United States risks the same fate unless it adopts pro-growth policy, faster permitting, and tougher trade enforcement to keep chemical production onshore.
Investment in Europe’s chemicals sector plunged and factories shut, turning a productive industrial backbone into a shrinking shadow of itself. Tens of thousands of jobs and millions of tons of capacity vanished in a few short years, showing how quickly a complex supply chain can be eroded. This is not an abstract trend; it affects everything from manufacturing inputs to defense readiness.
Energy costs and regulatory burdens are at the heart of the problem in Europe, leaving producers squeezed and capital flight inevitable. Chemicals are energy intensive, and policies that raise feedstock and compliance costs push production to lower-cost competitors. Add carbon pricing and slow permitting, and investors naturally look for places with predictable rules and cheaper inputs.
Chinese producers have exploited that gap by securing cheap feedstock and scaling capacity, then using pricing power to take market share worldwide. That structural advantage undercuts Western manufacturers that operate under tight environmental rules and higher input costs. When markets tilt like that, plants close here and jobs move there, often permanently.
TRUMP’S $12B RARE EARTH PLAN TARGETS CHINA AS EXPERTS WARN US IS ‘ONE CRISIS AWAY’
The strategic consequences are serious. “If you want a defense sector… an automotive sector, it’s totally dependent on chemicals supplying the materials.” Dependency on foreign suppliers for key chemical inputs means vulnerabilities in supply chains that matter for national security. Europe already sources critical items like vitamins and other chemical building blocks from China to an alarming degree.
Some in Washington might assume the U.S. is immune because of shale gas and a friendlier investment climate, but similar pressures are emerging here. Regulatory expansion and enforcement, permitting delays, and an uneven international playing field are squeezing margins and discouraging new capacity. Recent federal rulemaking under the Toxic Substances Control Act has broadened authority in ways that increase compliance costs and uncertainty for producers.
American firms have felt the consequences firsthand, shifting or closing capacities when economics turned against them. Even U.S.-based producers have shuttered plants or scaled back projects when global competition and regulatory unpredictability made investments unattractive. Those local decisions add up to a national trend: less domestic capacity, fewer skilled manufacturing jobs, and more reliance on foreign supply.
That does not mean environmental goals must be abandoned, but policy makers need to balance ambition with realism and competitiveness. Faster permitting, clearer regulatory timelines, and market-sensitive climate policy will keep investment in America. Recognizing chemicals as strategic industry means tailoring rules that protect safety and the environment without driving productive capacity overseas.
Trade enforcement matters as well. If foreign competitors benefit from discounted feedstock or distorted markets, U.S. firms will keep losing ground unless rules are enforced and unfair practices countered. A practical industrial strategy combines streamlined regulations, targeted incentives for onshoring, and aggressive enforcement to level the field.
Companies and communities depend on predictable policy that supports American jobs and national security interests. Lawmakers should act to ensure that the United States does not repeat Europe’s mistakes: slow permitting, unpredictable regulation, and tolerance of a hollowed-out industrial base. The choice is whether to keep critical chemical production here or watch it move offshore.
